Call Us Today!
(225) 706-8424

2012 Performance

Accountable Care Organization 2012 Quality Performance Report Summary Statistics Report
TP-ACO L.L.C.
Domain Measure Number Measure Name   TP-ACO Performance Rate  Mean Performance Rate All ACOs 
Patient/Caregiver Experience ACO-1 Getting Timely Care, Appointments, and Information 85.28 81.69
ACO-2 How Well Your Doctors Communicate 94.44 92.84
ACO-3 Patients’ Rating of Doctor 92.97 91.86
ACO-4 Access to Specialists 86.71 85.11
ACO-5 Health Promotion and Education 59.96 56.61
ACO-6 Shared Decision Making 76.65 73.99
ACO-7 Health Status/Functional Status 69.73 70.35
Care Coordination/Patient Safety ACO-8 Risk Standardized, All Condition Readmissions 16.29 15.42
ACO-9 ASC Admissions: COPD or Asthma in Older Adults 1.40 1.13
ACO-10 ASC Admission: HF 1.11 1.09
ACO-11 Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment 38.78% 59.87%
ACO-12 Medication Reconciliation 98.10% 72.37%
ACO-13 Falls: Screening for Fall Risk 22.35% 28.27%
Preventive Health ACO-14 Influenza Immunization 52.61% 50.58%
ACO-15 Pneumococcal Vaccination 56.99% 48.62%
ACO-16 Adult Weight Screening and Follow-up 50.57% 53.91%
ACO-17 Tobacco Use Assessment and Cessation Intervention 94.63% 80.12%
ACO-18 Depression Screening 28.34% 22.48%
ACO-19 Colorectal Cancer Screening 66.39% 50.21%
ACO-20 Mammography Screening 65.58% 62.23%
ACO-21 Proportion of Adults who had blood pressure screened in past 2 years 87.41% 71.56%
At Risk Population Diabetes Composite Beneficiaries with diabetes who met of all the following criteria: 12.00% 22.78%
ACO-22 Hemoglobin A1c Control (HbA1c) (<8 percent) 54.40% 64.46%
ACO-23 Low Density Lipoprotein (LDL) (< 100 mg/dL) 38.60% 52.99%
ACO-24 Blood Pressure (BP) < 140/90 49.80% 66.04%
ACO-25 Tobacco Non-Use 74.00% 71.72%
ACO-26 Aspirin Use 56.35% 72.24%
ACO-27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 36.00% 25.94%
ACO-28 Percent of beneficiaries with hypertension whose BP < 140/90 46.80% 63.22%
ACO-29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl 36.72% 52.02%
ACO-30 Percent of beneficiaries who use Aspirin or other antithrombotic 61.85% 72.60%
ACO-31 Beta-Blocker Therapy for LVSD 74.03% 79.60%
CAD Composite Percent of beneficiaries with CAD  who met all of the following criteria: 62.41% 61.69%
ACO-32 Drug Therapy for Lowering LDL-Cholesterol 66.83% 69.67%
ACO-33 (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) 75.49% 69.71%